19 May 2013
Keywords: qlt, acquires, full, rights, aczone, canadian, biopharmaceutical
Article | 11 July 2005
Canadian biopharmaceutical group QLT says it will acquire full rights to Aczone gel for the treatment of inflammatory and non-inflammatory
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
17 May 2013
© 2013 thepharmaletter.com